Summary:
A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adult Subjects with Moderate or Severe Diabetic Foot Infections
Qualified Participants Must:
• 18 years of age or older
•
Diagnosed with diabetes mellitus (type 1 or 2)
•
Diabetic foot infection (DFI) *Started at or below the malleolus and does not extend above the knee
Qualified Participants May Receive:
* Compensation for your time and travel will be up to $950